Annual ROA
-59.27%
-21.20%-55.69%
December 31, 2023
Summary
- As of March 12, 2025, AVTE annual return on assets is -59.27%, with the most recent change of -21.20% (-55.69%) on December 31, 2023.
- During the last 3 years, AVTE annual ROA has risen by +144.57% (+70.92%).
- AVTE annual ROA is now -352.79% below its all-time high of -13.09%, reached on December 31, 2021.
Performance
AVTE ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-77.47%
-5.21%-7.21%
September 30, 2024
Summary
- As of March 12, 2025, AVTE quarterly return on assets is -77.47%, with the most recent change of -5.21% (-7.21%) on September 30, 2024.
- Over the past year, AVTE quarterly ROA has dropped by -22.39% (-40.65%).
- AVTE quarterly ROA is now -266.81% below its all-time high of -21.12%, reached on March 31, 2022.
Performance
AVTE Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
AVTE ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.7% | -40.6% |
| 3 y3 years | +70.9% | -40.6% |
| 5 y5 years | +37.5% | -40.6% |
AVTE ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -352.8% | at low | -266.8% | at low |
| 5 y | 5-year | -352.8% | +70.9% | -266.8% | +62.0% |
| alltime | all time | -352.8% | +70.9% | -266.8% | +62.0% |
Aerovate Therapeutics ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -77.47%(+7.2%) |
| Jun 2024 | - | -72.26%(+16.7%) |
| Mar 2024 | - | -61.93%(+12.4%) |
| Dec 2023 | -59.27%(+55.7%) | -55.08%(+9.2%) |
| Sep 2023 | - | -50.42%(+10.6%) |
| Jun 2023 | - | -45.57%(+12.3%) |
| Mar 2023 | - | -40.58%(+19.3%) |
| Dec 2022 | -38.07% | -34.02%(+22.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -27.70%(+26.6%) |
| Jun 2022 | - | -21.88%(+3.6%) |
| Mar 2022 | - | -21.12%(-0.7%) |
| Dec 2021 | -13.09%(-93.6%) | -21.27%(-24.5%) |
| Sep 2021 | - | -28.18%(-50.2%) |
| Jun 2021 | - | -56.54%(-62.2%) |
| Mar 2021 | - | -149.44%(-26.7%) |
| Dec 2020 | -203.84%(+115.1%) | -203.84% |
| Dec 2019 | -94.76% | - |
FAQ
- What is Aerovate Therapeutics annual return on assets?
- What is the all time high annual ROA for Aerovate Therapeutics?
- What is Aerovate Therapeutics annual ROA year-on-year change?
- What is Aerovate Therapeutics quarterly return on assets?
- What is the all time high quarterly ROA for Aerovate Therapeutics?
- What is Aerovate Therapeutics quarterly ROA year-on-year change?
What is Aerovate Therapeutics annual return on assets?
The current annual ROA of AVTE is -59.27%
What is the all time high annual ROA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high annual return on assets is -13.09%
What is Aerovate Therapeutics annual ROA year-on-year change?
Over the past year, AVTE annual return on assets has changed by -21.20% (-55.69%)
What is Aerovate Therapeutics quarterly return on assets?
The current quarterly ROA of AVTE is -77.47%
What is the all time high quarterly ROA for Aerovate Therapeutics?
Aerovate Therapeutics all-time high quarterly return on assets is -21.12%
What is Aerovate Therapeutics quarterly ROA year-on-year change?
Over the past year, AVTE quarterly return on assets has changed by -22.39% (-40.65%)